NEWS
Consider Enrollment in the iNTD
We are close to the beginning of an NIH-funded study that will carry out a 5-year Natural History of SSADH (succinic semialdehyde dehydrogenase deficiency). This study will include clinical data (imaging, electrophysiology, neuropsychiatric evaluation, etc) and biomarker data (blood, urine, CSF, saliva, DNA, etc).
Primary intake site for patients in the USA will be at Boston Children’s Hospital, under the direction of Dr. Phillip Pearl.
I
We encourage you to consider enrollment of the iNTD. This would make the transfer of patient data between iNTD and our study facile, and benefit both sources. The iNTD group already has 15 enrolled patients with SSADH. The easiest way to enroll is to contact Kathrin Jeltsch at the iNTD directly by email at:
Kathrin.Jeltsch@med.uni-heidelberg.de